tirzepatide cv outcomes In patients with type 2 diabetes and atherosclerotic cardiovascular disease, was noninferior to dulaglutide with respect to major cardiovascular events. ⁣, ⁣, Read the full SURPASS-CVOT 💉 In a large real-world

Conversely, if you forget to inject on your scheduled day, your provider will advise you to inject as soon as you remember, then resume your normal weekly schedule

The eligibility criteria for Tirzepatide are a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related health condition

Their call-to-action includes: Build and support multidisciplinary teams of frontline clinicians, community partners, physiologists and behavioral and pharmaceutical scientists to address the knowledge gap in GLP-1RA effects in children and adolescents

On this episode of Monday Health Minutes, Melanie Shafer talks with Valley Health family physician Dr